Chinese Journal of Natural Medicines

Papers
(The H4-Index of Chinese Journal of Natural Medicines is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
New tirucallane-type triterpenoids from the resin of Boswellia carteriiand their NO inhibitory activities60
20(S)-ginsenoside Rh1 alleviates T2DM induced liver injury via the Akt/FOXO1 pathway29
New antibacterial depsidones from an ant-derived fungus Spiromastix sp. MY-123
Recent progress on anti-Candida natural products19
The anti-neoplastic activities of aloperine in HeLa cervical cancer cells are associated with inhibition of the IL-6-JAK1-STAT3 feedback loop15
Ziyuglycoside II inhibits the growth of digestive system cancer cells through multiple mechanisms14
Buqi-Tongluo Decoction inhibits osteoclastogenesis and alleviates bone loss in ovariectomized rats by attenuating NFATc1, MAPK, NF-κB signaling13
Flavonoids from the roots and rhizomes of Sophora tonkinensis and their in vitro anti-SARS-CoV-2 activity13
Heme peroxidases are responsible for the dehydrogenation and oxidation metabolism of harmaline into harmine12
Recent advances, strategies, and future perspectives of peptide-based drugs in clinical applications12
Traditional Chinese medicine enables the development of small-molecule inhibitors of HSP47, future therapeutic implication in venous thromboembolism12
Research progress of small-molecule natural medicines for the treatment of ischemic stroke12
0.032691955566406